Burning Rock Biotech Limited (BNR) Tops Q2 EPS by 9c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q2 EPS of (RMB1.28), RMB0.09 better than the analyst estimate of (RMB1.37). Revenue for the quarter came in at RMB146.3 million versus the consensus estimate of RMB173 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance